MHRA joins international partnerships to set global standards for medicines and medical devices regulation (Cell and Gene Therapy Catapult – Regulatory Round-up – June 2022)
The MHRA announced they have been accepted as a full member of three international work-sharing partnerships.
The MHRA has partnered with the International Medical Device Regulatory Forum (IMDRF) and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) to share expertise with other leading organisations, support the development of regulatory guidelines, drive greater harmonisation of regulation around the world.
The MHRA has also been accepted as a member of the US-based Medical Devices Innovation Consortium (MDIC). This enables transformational medical technology to get to the people who need it sooner, by shortening the path from innovation to safety to access.
Read about the news on the United Kingdom’s government website by following this link. Published on the 16th of June 2022.
See all of Catapult’s Regulatory Round-up for June 2022 here. Published on the 1st of July 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (26 octobre 2022). MHRA joins international partnerships to set global standards for medicines and medical devices regulation (Cell and Gene Therapy Catapult – Regulatory Round-up – June 2022). ELSIBI. Consulté le 16 janvier 2025 à l’adresse https://doi.org/10.58079/o63z
